A novel in silico reverse-transcriptomics-based identification and blood-based validation of a panel of sub-type specific biomarkers in lung cancer

Lung cancer accounts for the highest number of cancer-related deaths worldwide. Early diagnosis significantly increases the disease-free survival rate and a large amount of effort has been expended in screening trials and the development of early molecular diagnostics. However, a gold standard diagn...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Barh, Debmalya, Jain, Neha, Tiwari, Sandeep, Field, John K, Padin-Iruegas, Elena, Ruibal, Alvaro, López, Rafael, Herranz, Michel, Bhattacharya, Antaripa, Juneja, Lucky, Viero, Cedric, Silva, Artur, Miyoshi, Anderson, Kumar, Anil, Blum, Kenneth, Azevedo, Vasco, Ghosh, Preetam, Liloglou, Triantafillos
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BioMed Central 2013
Pynciau:
Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3908344/
https://ncbi.nlm.nih.gov/pubmed/24564251
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2164-14-S6-S5
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg